Publicaciones en las que colabora con Francisco Abad Santos (5)

2023

  1. APRIL: A double-blind, placebo-controlled, randomized, Phase Ib/IIa clinical study of ApTOLL for the treatment of acute ischemic stroke

    Frontiers in Neurology, Vol. 14

  2. Safety and Efficacy of ApTOLL in Patients with Ischemic Stroke Undergoing Endovascular Treatment: A Phase 1/2 Randomized Clinical Trial

    JAMA Neurology, Vol. 80, Núm. 8, pp. 779-788

2022

  1. First-in-human phase I clinical trial of a TLR4-binding DNA aptamer, ApTOLL: Safety and pharmacokinetics in healthy volunteers

    Molecular Therapy - Nucleic Acids, Vol. 28, pp. 124-135

2019

  1. A Neutrophil Timer Coordinates Immune Defense and Vascular Protection

    Immunity, Vol. 50, Núm. 2, pp. 390-402.e10

  2. Erratum: “A Neutrophil Timer Coordinates Immune Defense and Vascular Protection” (Immunity (2019) 50(2) (390–402.e10), (S1074761319300020), (10.1016/j.immuni.2019.01.002))

    Immunity